Navigating the Complex Landscape of ALS Drug Development Lessons Learned from the Withdrawal of Relyvrio

The recent decision by Amylyx Pharmaceuticals to withdraw its drug, Relyvrio, from the market following disappointing results in a large study has sent shockwaves through the ALS community and raised critical questions about the future of ALS drug development. This article explores the implications of Relyvrio’s withdrawal, examines the challenges faced in ALS drug development, …

Paralyzed Man Tweets Using Just By Thinking About It!

Anything is possible nowadays. You ought to just think and technological movements will wrap up. Taking everything into account, we are totally not kidding, it’s substantial. A paralyzed man, not set in stone to have amyotrophic lateral sclerosis (ALS), has had the choice to make a post on social media “using simply direct thought” in …

Exit mobile version